Cargando…
Advances in the Development of PET Ligands Targeting Histone Deacetylases for the Assessment of Neurodegenerative Diseases
Epigenetic alterations of gene expression have emerged as a key factor in several neurodegenerative diseases. In particular, inhibitors targeting histone deacetylases (HDACs), which are enzymes responsible for deacetylation of histones and other proteins, show therapeutic effects in animal neurodege...
Autores principales: | Tago, Tetsuro, Toyohara, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6017260/ https://www.ncbi.nlm.nih.gov/pubmed/29385079 http://dx.doi.org/10.3390/molecules23020300 |
Ejemplares similares
-
Histone Deacetylases Inhibitors in Neurodegenerative Diseases, Neuroprotection and Neuronal Differentiation
por: Shukla, Surabhi, et al.
Publicado: (2020) -
Understanding the Role of Histone Deacetylase and their Inhibitors in Neurodegenerative Disorders: Current Targets and Future Perspective
por: Kumar, Vishal, et al.
Publicado: (2022) -
Histone Deacetylase Inhibitor Alleviates the Neurodegenerative Phenotypes and Histone Dysregulation in Presenilins-Deficient Mice
por: Cao, Ting, et al.
Publicado: (2018) -
Targeting histone deacetylases for the treatment of disease
por: Lawless, M W, et al.
Publicado: (2009) -
Targeted inhibition of histone deacetylase 6 in inflammatory diseases
por: Ran, Jie, et al.
Publicado: (2019)